Discovery Laboratories, Inc. · Warrington, PA United States (NASDAQ: DSCO)

Discovery Laboratories, Inc. Rankings

Company Description

If you're waiting to exhale, Discovery Laboratories may be able to help. The biotechnology company focuses on treatments for respiratory disorders, particularly for babies in intensive care. Its lead candidate, Surfaxin, gained FDA in 2012 for the prevention of respiratory distress syndrome (RDS) in premature infants. Discovery Labs bases its therapies on surfactants, which are naturally produced by the lungs and essential for breathing. Another candidate, Aerosurf, will allow for the delivery of RDS surfactant medicine in aerosol form, and is being developed as an alternative to endotracheal intubation and conventional mechanical ventilation. The firm also makes respiratory drug delivery devices.

Financials

Executives

30 executives listed for Discovery Laboratories, Inc.'s Warrington, PA location.

More Discovery Laboratories, Inc. Executives

Top Discovery Laboratories, Inc. Competitors

• Abbott Laboratories
• Boehringer Ingelheim Corporation
• Forest Laboratories, Inc.